Correlation Between Johnson Johnson and Lexicon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Lexicon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Lexicon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Lexicon Pharmaceuticals, you can compare the effects of market volatilities on Johnson Johnson and Lexicon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Lexicon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Lexicon Pharmaceuticals.
Diversification Opportunities for Johnson Johnson and Lexicon Pharmaceuticals
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Johnson and Lexicon is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Lexicon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexicon Pharmaceuticals and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Lexicon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexicon Pharmaceuticals has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Lexicon Pharmaceuticals go up and down completely randomly.
Pair Corralation between Johnson Johnson and Lexicon Pharmaceuticals
Considering the 90-day investment horizon Johnson Johnson is expected to generate 0.08 times more return on investment than Lexicon Pharmaceuticals. However, Johnson Johnson is 11.92 times less risky than Lexicon Pharmaceuticals. It trades about -0.21 of its potential returns per unit of risk. Lexicon Pharmaceuticals is currently generating about -0.35 per unit of risk. If you would invest 16,160 in Johnson Johnson on August 28, 2024 and sell it today you would lose (582.00) from holding Johnson Johnson or give up 3.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Johnson Johnson vs. Lexicon Pharmaceuticals
Performance |
| Timeline |
| Johnson Johnson |
| Lexicon Pharmaceuticals |
Johnson Johnson and Lexicon Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Johnson Johnson and Lexicon Pharmaceuticals
The main advantage of trading using opposite Johnson Johnson and Lexicon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Lexicon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexicon Pharmaceuticals will offset losses from the drop in Lexicon Pharmaceuticals' long position.| Johnson Johnson vs. Capricor Therapeutics | Johnson Johnson vs. Soleno Therapeutics | Johnson Johnson vs. Bio Path Holdings | Johnson Johnson vs. Moleculin Biotech |
| Lexicon Pharmaceuticals vs. BioLineRx | Lexicon Pharmaceuticals vs. Ardelyx | Lexicon Pharmaceuticals vs. Seres Therapeutics | Lexicon Pharmaceuticals vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |